ProCite
RefWorks
Reference Manager
BibTeX
Zotero
EndNote
-
1.
van Veen NH, Nicholls PG, Smith WC, Richardus JH, 2008. Corticosteroids for treating nerve damage in leprosy. A Cochrane review. Lepr Rev 79: 361–371.
-
2.
Kahawita IP, Walker SL, Lockwood DN, 2008. Leprosy type 1 reactions and erythema nodosum leprosum. An Bras Dermatol 83: 75–82.
-
3.
Posey DL, Blackburn BG, Weinberg M, Flagg EW, Ortega L, Wilson M, Secor WE, Sanders-Lewis K, Won K, Maguire JH, 2007. High prevalence and presumptive treatment of schistosomiasis and strongyloidiasis among African refugees. Clin Infect Dis 45: 1310–1315.
-
4.
Pelletier LL Jr, Baker CB, Gam AA, Nutman TB, Neva FA, 1988. Diagnosis and evaluation of treatment of chronic strongyloidiasis in ex-prisoners of war. J Infect Dis 157: 573–576.
-
5.
Milder JE, Walzer PD, Kilgore G, Rutherford I, Klein M, 1981. Clinical features of Strongyloides stercoralis infection in an endemic area of the United States. Gastroenterology 80: 1481–1488.
-
6.
Buonfrate D, Requena-Mendez A, Angheben A, Muñoz J, Gobbi F, Van Den Ende J, Bisoffi Z, 2013. Severe strongyloidiasis: a systematic review of case reports. BMC Infect Dis 13: 78.
-
7.
Ghosh K, Ghosh K, 2007. Strongyloides stercoralis septicaemia following steroid therapy for eosinophilia: report of three cases. Trans R Soc Trop Med Hyg 101: 1163–1165.
-
8.
Centers for Disease Control and Prevention, 1997. Immunization of Health-Care Workers: Recommendations of the Advisory Committee on Immunization Practices (ACIP) and the Hospital Infection Control Practices Advisory Committee (HICPAC). MMWR Morb Mortal Wkly Rep 46: 1–42.
-
9.
Marzano A, Angelucci E, Andreone P, Brunetto M, Bruno R, Burra P, Caraceni P, Daniele B, Marco VD, Fabrizi F, Fagiuoli S, Grossi P, Lampertico P, Meliconi R, Mangia A, Puoti M, Raimondo G, Smedile A, 2007. Prophylaxis and treatment of hepatitis B in immunocompromised patients. Dig Liver Dis 39: 397–408.
-
10.
Martel N, Cotte L, Trabaud M-A, Trepo C, Zoulim F, Gomes SA, Key A, 2012. Probable corticosteroid-induced reactivation of latent hepatitis B virus infection in an HIV-positive patient involving immune escape. J Infect Dis 205: 1757–1761.
-
11.
Lockwood DNJ, Lambert SM, 2010. Leprosy and HIV, where are we at? Lepr Rev 81: 169–175.
-
12.
Magill AJ, Reed SG, 2000. American Trypanosomiasis. Strickland GT, ed. Hunter's Tropical Medicine and Emerging Infectious Diseases. Eighth edition. Philadelphia, PA: W.B. Saunders Company, 653–664.
-
13.
Walker M, Zunt JR, 2005. Parasitic central nervous system infections in immunocompromised hosts. Clin Infect Dis 40: 1005–1015.
-
14.
Trindade MÃ, Carvalho NB, Belfort EC, Pagliari C, Gakiya E, Sakai-Valente NY, Benard G, Shikanai-Yasuda MA, 2011. A patient with erythema nodosum leprosum and Chagas cardiopathy: challenges in patient management and review of the literature. Am J Trop Med Hyg 84: 973–977.
| Past two years | Past Year | Past 30 Days | |
|---|---|---|---|
| Abstract Views | 146 | 130 | 16 |
| Full Text Views | 236 | 7 | 1 |
| PDF Downloads | 64 | 6 | 1 |
Co-Morbid Infections in Hansen's Disease Patients in the United States: Considerations for Treatment
Madeline Bilodeau
Madeline Bilodeau
Department of Infectious Diseases, Department of Dermatology, and Department of Laboratory Medicine, Lahey Clinic Medical Center, Burlington, Massachusetts
Search for other papers by Madeline Bilodeau in
Current site
Google Scholar
PubMed
Search for other papers by Madeline Bilodeau in
Current site
Google Scholar
PubMed
Stephanie Burns
Stephanie Burns
Department of Infectious Diseases, Department of Dermatology, and Department of Laboratory Medicine, Lahey Clinic Medical Center, Burlington, Massachusetts
Search for other papers by Stephanie Burns in
Current site
Google Scholar
PubMed
Search for other papers by Stephanie Burns in
Current site
Google Scholar
PubMed
John Gawoski
John Gawoski
Department of Infectious Diseases, Department of Dermatology, and Department of Laboratory Medicine, Lahey Clinic Medical Center, Burlington, Massachusetts
Search for other papers by John Gawoski in
Current site
Google Scholar
PubMed
Search for other papers by John Gawoski in
Current site
Google Scholar
PubMed
Samuel Moschella
Samuel Moschella
Department of Infectious Diseases, Department of Dermatology, and Department of Laboratory Medicine, Lahey Clinic Medical Center, Burlington, Massachusetts
Search for other papers by Samuel Moschella in
Current site
Google Scholar
PubMed
Search for other papers by Samuel Moschella in
Current site
Google Scholar
PubMed
Winnie Ooi
Winnie Ooi
Department of Infectious Diseases, Department of Dermatology, and Department of Laboratory Medicine, Lahey Clinic Medical Center, Burlington, Massachusetts
Search for other papers by Winnie Ooi in
Current site
Google Scholar
PubMed
Search for other papers by Winnie Ooi in
Current site
Google Scholar
PubMed
120 patients attending a Hansen's disease public health satellite clinic were evaluated for selected latent co-morbidities, consisting of strongyloidiasis, Chagas disease, hepatitis B, HIV, and tuberculosis, and potential exacerbation by immunosuppressive therapy. Implications for treatment of Hansen's disease are discussed.
Author Notes
Authors' addresses: Madeline Bilodeau, and Winnie Ooi, Department of Infectious Diseases, Lahey Hospital & Medical Center, Burlington, MA, E-mails: bilodeau.ma@husky.neu.edu, and winnie.w.ooi@lahey.org. Stephanie Burns and Samuel Moschella, Department of Dermatology, Lahey Hospital and Medical Center, Burlington, MA, E-mails: stephanie.a.burns@lahey.org and samuel.l.moschella@lahey.org. John Gawoski, Department of Laboratory Medicine, Lahey Hospital & Medical Center, Burlington, MA, E-mail: john.m.gawoski@lahey.org.
ProCite
RefWorks
Reference Manager
BibTeX
Zotero
EndNote
-
1.
van Veen NH, Nicholls PG, Smith WC, Richardus JH, 2008. Corticosteroids for treating nerve damage in leprosy. A Cochrane review. Lepr Rev 79: 361–371.
-
2.
Kahawita IP, Walker SL, Lockwood DN, 2008. Leprosy type 1 reactions and erythema nodosum leprosum. An Bras Dermatol 83: 75–82.
-
3.
Posey DL, Blackburn BG, Weinberg M, Flagg EW, Ortega L, Wilson M, Secor WE, Sanders-Lewis K, Won K, Maguire JH, 2007. High prevalence and presumptive treatment of schistosomiasis and strongyloidiasis among African refugees. Clin Infect Dis 45: 1310–1315.
-
4.
Pelletier LL Jr, Baker CB, Gam AA, Nutman TB, Neva FA, 1988. Diagnosis and evaluation of treatment of chronic strongyloidiasis in ex-prisoners of war. J Infect Dis 157: 573–576.
-
5.
Milder JE, Walzer PD, Kilgore G, Rutherford I, Klein M, 1981. Clinical features of Strongyloides stercoralis infection in an endemic area of the United States. Gastroenterology 80: 1481–1488.
-
6.
Buonfrate D, Requena-Mendez A, Angheben A, Muñoz J, Gobbi F, Van Den Ende J, Bisoffi Z, 2013. Severe strongyloidiasis: a systematic review of case reports. BMC Infect Dis 13: 78.
-
7.
Ghosh K, Ghosh K, 2007. Strongyloides stercoralis septicaemia following steroid therapy for eosinophilia: report of three cases. Trans R Soc Trop Med Hyg 101: 1163–1165.
-
8.
Centers for Disease Control and Prevention, 1997. Immunization of Health-Care Workers: Recommendations of the Advisory Committee on Immunization Practices (ACIP) and the Hospital Infection Control Practices Advisory Committee (HICPAC). MMWR Morb Mortal Wkly Rep 46: 1–42.
-
9.
Marzano A, Angelucci E, Andreone P, Brunetto M, Bruno R, Burra P, Caraceni P, Daniele B, Marco VD, Fabrizi F, Fagiuoli S, Grossi P, Lampertico P, Meliconi R, Mangia A, Puoti M, Raimondo G, Smedile A, 2007. Prophylaxis and treatment of hepatitis B in immunocompromised patients. Dig Liver Dis 39: 397–408.
-
10.
Martel N, Cotte L, Trabaud M-A, Trepo C, Zoulim F, Gomes SA, Key A, 2012. Probable corticosteroid-induced reactivation of latent hepatitis B virus infection in an HIV-positive patient involving immune escape. J Infect Dis 205: 1757–1761.
-
11.
Lockwood DNJ, Lambert SM, 2010. Leprosy and HIV, where are we at? Lepr Rev 81: 169–175.
-
12.
Magill AJ, Reed SG, 2000. American Trypanosomiasis. Strickland GT, ed. Hunter's Tropical Medicine and Emerging Infectious Diseases. Eighth edition. Philadelphia, PA: W.B. Saunders Company, 653–664.
-
13.
Walker M, Zunt JR, 2005. Parasitic central nervous system infections in immunocompromised hosts. Clin Infect Dis 40: 1005–1015.
-
14.
Trindade MÃ, Carvalho NB, Belfort EC, Pagliari C, Gakiya E, Sakai-Valente NY, Benard G, Shikanai-Yasuda MA, 2011. A patient with erythema nodosum leprosum and Chagas cardiopathy: challenges in patient management and review of the literature. Am J Trop Med Hyg 84: 973–977.
| Past two years | Past Year | Past 30 Days | |
|---|---|---|---|
| Abstract Views | 146 | 130 | 16 |
| Full Text Views | 236 | 7 | 1 |
| PDF Downloads | 64 | 6 | 1 |